Skip to main content
IC
Genome & Company (KOSDAQ:314130)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,515.00
-25.00 (-0.98%)
At close: May 13, 2025, 3:30 PM KST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Service
7.86B
Log In
Log In
Log In
Log In
Service Growth
6.06%
Log In
Log In
Log In
Log In
Immuno-cancer Drugs - Product
6.21B
Log In
Log In
Log In
Log In
Immuno-cancer Drugs - Product Growth
-3.87%
Log In
Log In
Log In
Log In
Usage Fee
211.93M
Log In
Log In
Log In
Log In
Usage Fee Growth
-0.13%
Log In
Log In
Log In
Log In
Immuno-cancer Drugs - Merchandise
15.50M
Log In
Log In
Log In
Log In
Immuno-cancer Drugs - Merchandise Growth
496.15%
Log In
Log In
Log In
Log In
Biological Products
-
Log In
Log In
Log In
Log In
Biological Products Growth
-
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
South Korea
14.30B
Log In
Log In
Log In
Log In
South Korea Growth
1.50%
Log In
Log In
Log In
Log In